Denis Roy

728 total citations
9 papers, 219 citations indexed

About

Denis Roy is a scholar working on Surgery, Endocrinology, Diabetes and Metabolism and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Denis Roy has authored 9 papers receiving a total of 219 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Surgery, 5 papers in Endocrinology, Diabetes and Metabolism and 3 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Denis Roy's work include Diabetes Treatment and Management (5 papers), Pancreatitis Pathology and Treatment (4 papers) and Pancreatic function and diabetes (4 papers). Denis Roy is often cited by papers focused on Diabetes Treatment and Management (5 papers), Pancreatitis Pathology and Treatment (4 papers) and Pancreatic function and diabetes (4 papers). Denis Roy collaborates with scholars based in United States, Canada and United Kingdom. Denis Roy's co-authors include David G. Parkes, Krystyna Tatarkiewicz, Gyo‐Jeong Gu, P M Bélanger, Bronislava Gedulin, Lisa C. Adams, Pam Smith, Christiane Villescaz, Diane M. Hargrove and Raja S. Mangipudy and has published in prestigious journals such as Diabetes, The American Journal of Cardiology and Cellular and Molecular Life Sciences.

In The Last Decade

Denis Roy

9 papers receiving 201 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Denis Roy United States 7 139 100 75 33 27 9 219
Andrew D. Howard United States 6 126 0.9× 97 1.0× 104 1.4× 21 0.6× 29 1.1× 6 274
Masayuki Miuchi Japan 13 281 2.0× 137 1.4× 87 1.2× 29 0.9× 23 0.9× 22 354
V. Médeau France 6 217 1.6× 150 1.5× 73 1.0× 9 0.3× 12 0.4× 9 304
Julia Schewe Germany 7 81 0.6× 66 0.7× 61 0.8× 25 0.8× 5 0.2× 11 148
Katharina Schütt Germany 8 62 0.4× 39 0.4× 192 2.6× 61 1.8× 10 0.4× 44 293
Jenna Elizabeth Hunt Denmark 10 205 1.5× 162 1.6× 108 1.4× 14 0.4× 21 0.8× 20 322
Xinqing Fan United States 9 27 0.2× 120 1.2× 140 1.9× 19 0.6× 20 0.7× 14 364
Tricia Santos Cavaiola United States 10 243 1.7× 123 1.2× 78 1.0× 12 0.4× 5 0.2× 14 343
Guillermo Arreaza-Rubín United States 8 75 0.5× 133 1.3× 31 0.4× 7 0.2× 52 1.9× 11 210
Erica Gonzalez United States 6 90 0.6× 49 0.5× 136 1.8× 14 0.4× 9 0.3× 8 258

Countries citing papers authored by Denis Roy

Since Specialization
Citations

This map shows the geographic impact of Denis Roy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Denis Roy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Denis Roy more than expected).

Fields of papers citing papers by Denis Roy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Denis Roy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Denis Roy. The network helps show where Denis Roy may publish in the future.

Co-authorship network of co-authors of Denis Roy

This figure shows the co-authorship network connecting the top 25 collaborators of Denis Roy. A scholar is included among the top collaborators of Denis Roy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Denis Roy. Denis Roy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Camm, A. John, Jonathan P. Piccini, Marco Alings, et al.. (2023). Multicenter, Phase 2, Randomized Controlled Study of the Efficacy and Safety of Etripamil Nasal Spray for the Acute Reduction of Rapid Ventricular Rate in Patients With Symptomatic Atrial Fibrillation (ReVeRA-201). Circulation Arrhythmia and Electrophysiology. 16(12). 639–650. 5 indexed citations
2.
Buss, Nicholas, Patricia C. Ryan, Todd M. Baughman, et al.. (2018). Nonclinical safety and pharmacokinetics of Miglyol 812: A medium chain triglyceride in exenatide once weekly suspension. Journal of Applied Toxicology. 38(10). 1293–1301. 14 indexed citations
3.
Roy, Denis, Krystyna Tatarkiewicz, Ann‐Marie Bergholm, et al.. (2014). The glucagon‐like peptide‐1‐based therapeutics exenatide and saxagliptin did not cause detrimental effects on the pancreas in mice, rats, dogs and monkeys. Diabetes Obesity and Metabolism. 16(10). 910–921. 13 indexed citations
4.
Fletcher, Anthony M., Susan Bonner‐Weir, Raja S. Mangipudy, et al.. (2013). Occurrence of Spontaneous Pancreatic Lesions in Normal and Diabetic Rats: A Potential Confounding Factor in the Nonclinical Assessment of GLP-1–Based Therapies. Diabetes. 63(4). 1303–1314. 29 indexed citations
5.
Tatarkiewicz, Krystyna, P M Bélanger, Gyo‐Jeong Gu, David G. Parkes, & Denis Roy. (2012). No evidence of drug‐induced pancreatitis in rats treated with exenatide for 13 weeks. Diabetes Obesity and Metabolism. 15(5). 417–426. 46 indexed citations
6.
Tatarkiewicz, Krystyna, Pam Smith, Christiane Villescaz, et al.. (2010). Exenatide does not evoke pancreatitis and attenuates chemically induced pancreatitis in normal and diabetic rodents. American Journal of Physiology-Endocrinology and Metabolism. 299(6). E1076–E1086. 75 indexed citations
7.
Guerra, Peter G., et al.. (1998). Is There a Future for Antiarrhythmic Drug Therapy?. Drugs. 56(5). 767–781. 22 indexed citations
8.
Blackshear, Joseph L., Bruce S. Stambler, William Strauss, et al.. (1996). Control of heart rate during transition from intravenous to oral diltiazem in atrial fibrillation or flutter. The American Journal of Cardiology. 78(11). 1246–1250. 10 indexed citations
9.
Sarkar, Saheli, et al.. (1975). Effect of cyproheptadine hydrochloride on spermatogenesis. Cellular and Molecular Life Sciences. 31(11). 1367–1368. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026